To include your compound in the COVID-19 Resource Center, submit it here.

Avelumab: Phase II data

Top-line data from 61 evaluable patients with metastatic MCC that has progressed following chemotherapy and who were followed for

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE